Advancing the Pipeline

Pfizer's pipeline of medicines in development is rich in Phase I and Phase II programs, backed by more proof of concept than ever before, and well-balanced between small molecules and large (protein-based) biologics and vaccines. We update our pipeline regularly—this chart reflects the pipeline update of February 28, 2011